JORDAN MEARS: Open Payments
NPI 1437847811 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 27 payments from 9 companies in 2025. Trend: 2023 $305 · 2024 $459 · 2025 $831
Food & beverage: $643Consulting: $189
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 13 | $250 |
| Alexion Pharmaceuticals, Inc. | 2 | $189 |
| Alnylam Pharmaceuticals Inc. | 2 | $134 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Lundbeck LLC | 2 | $39 |
| Amgen Inc. | 2 | $33 |
| Biogen, Inc. | 1 | $17 |
| ADMA BioManufacturing LLC | 1 | $14 |
Products named: Ocrevus Zunovo, ULTOMIRIS, ILUMYA, AMVUTTRA, VYEPTI, EVENITY, GIVLAARI, TYSABRI.
Industry payments across VA — which companies pay providers there.
